All Stories

  1. Brief Report

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, July 2015, Wolters Kluwer Health

    Dr Alejandro Vallejo

  2. Absence of HTLV-1/2 infection among HCV-infected patients with no HIV-1/2 infection in Spain

    Article • Journal of Clinical Virology, March 2015, Elsevier

    Dr Alejandro Vallejo

  3. Delayed liver fibrosis in HTLV-2-infected patients co-infected with HIV-1 and hepatitis C virus with suppressive antiretroviral therapy

    Article • AIDS, February 2015, Wolters Kluwer Health

    Dr Alejandro Vallejo

  4. Visceral leishmaniasis as an independent cause of high immune activation, T-cell senescence, and lack of immune recovery in virologically suppressed HIV-1-coinfected patients

    Article • HIV Medicine, January 2015, Wiley

    Dr Alejandro Vallejo, Dr Jose L Casado

  5. Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals

    Article • Mucosal Immunology, November 2014, Springer Science + Business Media

    Dr Alejandro Vallejo

  6. High levels of CD4+ CTLA-4+ Treg cells and CCR5 density in HIV-1-infected patients with visceral leishmaniasis

    Article • European Journal of Clinical Microbiology & Infectious Diseases, August 2014, Springer Science + Business Media

    Dr Alejandro Vallejo

  7. Effects of Different Antigenic Stimuli on Thymic Function and Interleukin-7/CD127 System in Patients with Chronic HIV Infection

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, August 2014, Wolters Kluwer Health

    Dr Alejandro Vallejo

  8. Expression of gut-homing β7 receptor on T cells: surrogate marker for microbial translocation in suppressed HIV-1-infected patients?

    Article • HIV Medicine, May 2014, Wiley

    Dr Alejandro Vallejo

  9. Transient increment of HTLV-2 proviral load in HIV-1-co-infected patients during treatment intensification with raltegravir

    Article • Journal of Clinical Virology, March 2014, Elsevier

    Dr Alejandro Vallejo

  10. CD8 TCR β chain repertoire expansions and deletions are related with immunologic markers in HIV-1-infected patients during treatment interruption

    Article • Journal of Clinical Virology, December 2013, Elsevier

    Dr Alejandro Vallejo

  11. Correlation Between Different Methods to Measure Microbial Translocation and Its Association With Immune Activation in Long-Term Suppressed HIV-1–Infected Individuals

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, October 2013, Wolters Kluwer Health

    Dr Alejandro Vallejo

  12. Dynamics of the HIV-1 latent reservoir after discontinuation of the intensification of antiretroviral treatment

    Article • AIDS, August 2013, Wolters Kluwer Health

    Dr Alejandro Vallejo, Sergio Serrano-Villar

  13. The CD4/CD8 ratio in HIV-infected subjects is independently associated with T-cell activation despite long-term viral suppression

    Article • Journal of Infection, January 2013, Elsevier

    Dr Alejandro Vallejo, Sergio Serrano-Villar

  14. The effect of intensification with raltegravir on the HIV-1 reservoir of latently infected memory CD4 T cells in suppressed patients

    Article • AIDS, September 2012, Wolters Kluwer Health

    Dr Alejandro Vallejo

  15. Intensification of Antiretroviral Therapy with a CCR5 Antagonist in Patients with Chronic HIV-1 Infection: Effect on T Cells Latently Infected

    Article • PLoS ONE, December 2011, PLOS

    Dr Jose L Casado, Dr Alejandro Vallejo

  16. Immunological characteristics of Spanish IDUs infected with HTLV-2 and HIV-1

    Article • Retrovirology, June 2011, Springer Science + Business Media

    Dr Alejandro Vallejo

  17. Prevalence and resistance mutations of non-B HIV-1 subtypes among immigrants in Southern Spain along the decade 2000-2010

    Article • Virology Journal, January 2011, Springer Science + Business Media

    Dr Alejandro Vallejo

  18. HTLV-2b Among HIV Type 1-Coinfected Injecting Drug Users in Spain

    Article • AIDS Research and Human Retroviruses, November 2010, Mary Ann Liebert Inc

    Dr Alejandro Vallejo

  19. Effect of 24 weeks of intensification with a CCR5-antagonist on the decay of the HIV-1 latent reservoir

    Article • Journal of the International AIDS Society, January 2010, Wiley

    Dr Alejandro Vallejo

  20. Premature immunosenescence in HIV-infected patients on highly active antiretroviral therapy with low-level CD4 T cell repopulation

    Article • Journal of Antimicrobial Chemotherapy, July 2009, Oxford University Press (OUP)

    Dr Alejandro Vallejo

  21. HCV RNA in peripheral blood cell subsets in HCV-HIV coinfected patients at the end of PegIFN/RBV treatment is associated with virologic relapse

    Article • Journal of Viral Hepatitis, January 2009, Wiley

    Dr Alejandro Vallejo

  22. Influence of the Toll-Like Receptor 9 1635A/G Polymorphism on the CD4 Count, HIV Viral Load, and Clinical Progression

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, October 2008, Wolters Kluwer Health

    Dr Alejandro Vallejo

  23. NK-Associated Regulatory Receptors in a Structured HAART Interruption of HIV-1-Positive Individuals

    Article • AIDS Research and Human Retroviruses, August 2008, Mary Ann Liebert Inc

    Dr Alejandro Vallejo

  24. Control of HIV-1 RNA load after HAART interruption: Relationship with CCR5 co-receptor density and proviral DNA load in HIV-infected patients

    Article • Journal of Clinical Virology, September 2007, Elsevier

    Dr Alejandro Vallejo

  25. Development and evaluation of HIV-1 subtype RNA panels for the standardization of HIV-1 NAT assays

    Article • Journal of Virological Methods, November 2006, Elsevier

    Dr Alejandro Vallejo

  26. Thymic Volume Predicts CD4 T-Cell Decline in HIV-Infected Adults Under Prolonged Treatment Interruption

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, June 2006, Wolters Kluwer Health

    Dr Alejandro Vallejo

  27. Disseminate and fatal cytomegalovirus disease with thymitis in a naive HIV-patient after early initiation of HAART: Immune restoration disease?

    Article • Journal of Clinical Virology, May 2006, Elsevier

    Dr Alejandro Vallejo

  28. High Thymic Volume Is Associated With Viral Replication and Immunologic Impairment Only Early After HAART Interruption in Chronic HIV Infection

    Article • Viral Immunology, December 2005, Mary Ann Liebert Inc

    Dr Alejandro Vallejo

  29. Prevalence and factors involved in discordant responses to highly active antiretroviral treatment in a closely followed cohort of treatment-naïve HIV-infected patients

    Article • Journal of Clinical Virology, June 2005, Elsevier

    Dr Alejandro Vallejo

  30. Effect of Hepatitis C Virus Coinfection on Humoral Immune Alterations in Naïve HIV-Infected Adults on HAART: A Three Year Follow-Up Study

    Article • Journal of Clinical Immunology, May 2005, Springer Science + Business Media

    Dr Alejandro Vallejo

  31. Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients

    Article • Journal of Medical Virology, January 2005, Wiley

    Dr Alejandro Vallejo, Dr. Vicente Soriano

  32. Thymic volume is associated independently with the magnitude of short- and long-term repopulation of CD4+ T cells in HIV-infected adults after highly active antiretroviral therapy (HAART)1

    Article • Clinical & Experimental Immunology, June 2004, Wiley

    Dr Alejandro Vallejo

  33. Infecciones por VIH-2 y HTLV-I/II en España

    Article • Enfermedades Infecciosas y Microbiología Clínica, March 2004, Elsevier

    Dr Alejandro Vallejo, Dr. Vicente Soriano, Enrique J. Calderon

  34. Genotypic resistance profile in treatment-experienced HIV-infected individuals after abacavir and efavirenz salvage regimen

    Article • Antiviral Research, February 2004, Elsevier

    Dr Alejandro Vallejo

  35. Infecciones por VIH-2 y HTLV-I/II en España

    Article • Enfermedades Infecciosas y Microbiología Clínica, January 2004, Elsevier

    Dr Alejandro Vallejo

  36. Cosmopolitan HTLV-Ia Subtype Among Spanish Native Patients

    Article • AIDS Research and Human Retroviruses, July 2003, Mary Ann Liebert Inc

    Dr Alejandro Vallejo, Enrique J. Calderon

  37. Nucleotide sequence analysis of the accessory genes of HIV-1 group O isolates

    Article • Virus Research, February 2003, Elsevier

    Dr Alejandro Vallejo

  38. V3-loop and nef gene sequences of HIV-1 isolates from a hemophiliac cohort with long-term non-progressive infection

    Article • AIDS, March 1999, Wolters Kluwer Health

    Dr Alejandro Vallejo, Dr. Vicente Soriano

  39. Tropism, Coreceptor Use, and Phylogenetic Analysis of Both the V3 Loop and the Protease Gene of Three Novel HIV-1 Group O Isolates

    Article • Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology, August 1998, Wolters Kluwer Health

    Dr Alejandro Vallejo, Antonio Mas, Dr. Vicente Soriano

  40. Letter to the Editor : Phylogenetic Analysis of HIV Type 2 Strains from Portugal

    Article • AIDS Research and Human Retroviruses, April 1998, Mary Ann Liebert Inc

    Dr Alejandro Vallejo, Dr. Vicente Soriano

  41. Absence of HTLV-1 Proviral Sequences in Patients with Lymphomatoid Papulosis

    Article • Journal of Investigative Dermatology, December 1997, Elsevier

    Dr Alejandro Vallejo

  42. Mycosis fungoides and Sezary syndrome are not associated with HTLV-I infection: an international study

    Article • British Journal of Haematology, September 1997, Wiley

    Dr Alejandro Vallejo, Dr. Vicente Soriano

  43. Chemokine receptors and HIV-2

    Article • AIDS, July 1997, Wolters Kluwer Health

    Dr Alejandro Vallejo, Dr. Vicente Soriano

  44. Genetic Analysis of an HIV Type 2 Subtype B Virus from a Spanish Individual with AIDS

    Article • AIDS Research and Human Retroviruses, July 1997, Mary Ann Liebert Inc

    Dr Alejandro Vallejo, Dr. Vicente Soriano

  45. Evidence of HIV-2 Infection in Equatorial Guinea (Central Africa): Partial Genetic Analysis of a B Subtype Virus

    Article • AIDS Research and Human Retroviruses, March 1997, Mary Ann Liebert Inc

    Dr Alejandro Vallejo, Dr. Vicente Soriano

  46. Long-term zidovudine responders: is there still rationale for HIV monotherapy?

    Article • AIDS, December 1996, Wolters Kluwer Health

    Dr Alejandro Vallejo, Dr. Vicente Soriano

  47. Nucleotide Sequence and Restriction Fragment-Length Polymorphism Analysis of Human T-Cell Lymphotropic Virus Type II (HTLV-II) in Southern Europe: Evidence for the HTLV-IIa and HTLV-IIb Subtypes

    Article • Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology, December 1996, Wolters Kluwer Health

    Dr Alejandro Vallejo, Dr. Vicente Soriano

  48. Epidemiology of human T-lymphotropic virus type II (HTLV-II) infection in Spain

    Article • European Journal of Epidemiology, December 1996, Springer Science + Business Media

    Dr Alejandro Vallejo, Dr. Vicente Soriano

  49. Development of a multiplex PCR assay for the simultaneous detection and discrimination of HIV-1, HIV-2, HTLV-I and HTLV-II

    Article • Clinical and Diagnostic Virology, November 1996, Elsevier

    Dr Alejandro Vallejo, Dr. Vicente Soriano

  50. Epidemiology of HIV-2 infection in Spain

    Article • European Journal of Clinical Microbiology & Infectious Diseases, May 1996, Springer Science + Business Media

    Dr Alejandro Vallejo, Dr. Vicente Soriano, Enrique J. Calderon

  51. Epidemiology of HTLV-I Infection in Spain

    Article • International Journal of Epidemiology, January 1996, Oxford University Press (OUP)

    Dr Alejandro Vallejo, Dr. Vicente Soriano

  52. Sequence Analysis of the V1/V2 and V3 Domains in an HIV-Seronegative AIDS Patient

    Article • AIDS Research and Human Retroviruses, December 1995, Mary Ann Liebert Inc

    Dr Alejandro Vallejo, Dr. Vicente Soriano

  53. HTLV-I-Associated Illnesses in Spain

    Article • Vox Sanguinis, October 1995, Wiley

    Dr Alejandro Vallejo, Dr. Vicente Soriano, Enrique J. Calderon

  54. Is Mycosis fungoides Associated with HTLV-I?

    Article • Vox Sanguinis, July 1995, Wiley

    Dr Alejandro Vallejo

  55. Enhancement of HIV Antigen Detection after Acid Dissociation of Immune Complexes Is Associated with Loss of Specificity

    Article • Vox Sanguinis, February 1995, Wiley

    Dr Alejandro Vallejo, Dr. Vicente Soriano

  56. HTLV-I and HTLV-II in Africans.

    Article • Sexually Transmitted Infections, February 1995, BMJ

    Dr Alejandro Vallejo

  57. Typing human T-cell lymphotropic virus (HTLV-I and HTLV-II) by nested polymerase chain reaction: application to clinical specimens

    Article • Journal of Virological Methods, January 1995, Elsevier

    Dr Alejandro Vallejo

  58. Seroreversion in Patients with End-Stage HIV Infection

    Article • Vox Sanguinis, August 1994, Wiley

    Dr Alejandro Vallejo, Dr. Vicente Soriano

  59. HTLV-I/II Infection among Immigrants to Spain

    Article • Vox Sanguinis, July 1994, Wiley

    Dr Alejandro Vallejo, Dr. Vicente Soriano

  60. HTLV-II Subtype b Among Injecting Drug Users in Spain

    Article • Vox Sanguinis, July 1994, Wiley

    Dr Alejandro Vallejo